Targeting transcription factors for therapeutic benefit in rheumatoid arthritis

Rheumatoid arthritis (RA) is a destructive inflammatory autoimmune disease that causes pain and disability. Many of the currently available drugs for treating RA patients are aimed at halting the progression of the disease and alleviating inflammation. Further, some of these treatment options have d...

Descripción completa

Detalles Bibliográficos
Autores principales: Balendran, Thivya, Lim, Keith, Hamilton, John A., Achuthan, Adrian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339812/
https://www.ncbi.nlm.nih.gov/pubmed/37457726
http://dx.doi.org/10.3389/fimmu.2023.1196931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339812/
https://www.ncbi.nlm.nih.gov/pubmed/37457726
http://dx.doi.org/10.3389/fimmu.2023.1196931

Ejemplares similares